The University of Southampton
University of Southampton Institutional Repository

Milk Thistle Treatment for Children and Adults with Trichotillomania: a Double-Blind, Placebo-Controlled, Crossover Negative Study

Milk Thistle Treatment for Children and Adults with Trichotillomania: a Double-Blind, Placebo-Controlled, Crossover Negative Study
Milk Thistle Treatment for Children and Adults with Trichotillomania: a Double-Blind, Placebo-Controlled, Crossover Negative Study

Background Data on the pharmacological treatment of trichotillomania are limited. Milk thistle has antioxidant properties and showed promise in trichotillomania in a prior case report. The goal of the current study was to determine the efficacy and tolerability of silymarin in children and adults with trichotillomania. Methods Twenty individuals (19 [95.0%] women; 16 adults; mean age, 27.9 [11.5] years) with trichotillomania entered a 12-week, double-blind, placebo-controlled crossover study (6 weeks of milk thistle and 6 weeks of placebo with a 1-week wash-out in between). Dosing of milk thistle ranged from 150 mg twice a day to 300 mg twice a day. Subjects were assessed with the National Institute of Mental Health Trichotillomania Severity Scale (primary outcome), the Massachusetts General Hospital Hair Pulling Scale, Clinical Global Impression scale, and measures of depression, anxiety, and psychosocial functioning. Outcomes were examined using linear mixed models with a random intercept for subject and t tests. Results There were no statistically significant treatment type-by-time interactions for the main outcome measure, but significant effects were seen for secondary measures (eg, time spent pulling per day for the past week). From baseline to week 6, there was a significant decrease in Clinical Global Impression severity for the milk thistle group but not in the placebo group. Conclusions This trial failed to show that milk thistle was more effective than placebo on the main outcome measure, but milk thistle did demonstrate significant improvements on select secondary outcome measures. These findings may shed light on important neurochemical targets worthy of future investigation.

milk thistle, natural supplement, silymarin, treatment, trichotillomania
0271-0749
129-134
Grant, Jon E.
07372bd5-8a0d-42b4-b41b-e376c652acf3
Redden, Sarah A.
f2109178-7158-46c7-971f-4a602a3adf59
Chamberlain, Samuel R.
8a0e09e6-f51f-4039-9287-88debe8d8b6f
Grant, Jon E.
07372bd5-8a0d-42b4-b41b-e376c652acf3
Redden, Sarah A.
f2109178-7158-46c7-971f-4a602a3adf59
Chamberlain, Samuel R.
8a0e09e6-f51f-4039-9287-88debe8d8b6f

Grant, Jon E., Redden, Sarah A. and Chamberlain, Samuel R. (2019) Milk Thistle Treatment for Children and Adults with Trichotillomania: a Double-Blind, Placebo-Controlled, Crossover Negative Study. Journal of Clinical Psychopharmacology, 39 (2), 129-134. (doi:10.1097/JCP.0000000000001005).

Record type: Article

Abstract

Background Data on the pharmacological treatment of trichotillomania are limited. Milk thistle has antioxidant properties and showed promise in trichotillomania in a prior case report. The goal of the current study was to determine the efficacy and tolerability of silymarin in children and adults with trichotillomania. Methods Twenty individuals (19 [95.0%] women; 16 adults; mean age, 27.9 [11.5] years) with trichotillomania entered a 12-week, double-blind, placebo-controlled crossover study (6 weeks of milk thistle and 6 weeks of placebo with a 1-week wash-out in between). Dosing of milk thistle ranged from 150 mg twice a day to 300 mg twice a day. Subjects were assessed with the National Institute of Mental Health Trichotillomania Severity Scale (primary outcome), the Massachusetts General Hospital Hair Pulling Scale, Clinical Global Impression scale, and measures of depression, anxiety, and psychosocial functioning. Outcomes were examined using linear mixed models with a random intercept for subject and t tests. Results There were no statistically significant treatment type-by-time interactions for the main outcome measure, but significant effects were seen for secondary measures (eg, time spent pulling per day for the past week). From baseline to week 6, there was a significant decrease in Clinical Global Impression severity for the milk thistle group but not in the placebo group. Conclusions This trial failed to show that milk thistle was more effective than placebo on the main outcome measure, but milk thistle did demonstrate significant improvements on select secondary outcome measures. These findings may shed light on important neurochemical targets worthy of future investigation.

This record has no associated files available for download.

More information

Published date: 1 March 2019
Additional Information: Publisher Copyright: © 2019 Wolters Kluwer Health, Inc. All rights reserved.
Keywords: milk thistle, natural supplement, silymarin, treatment, trichotillomania

Identifiers

Local EPrints ID: 493288
URI: http://eprints.soton.ac.uk/id/eprint/493288
ISSN: 0271-0749
PURE UUID: c3188388-4500-48eb-a4a9-62c6da49368e
ORCID for Samuel R. Chamberlain: ORCID iD orcid.org/0000-0001-7014-8121

Catalogue record

Date deposited: 29 Aug 2024 16:42
Last modified: 30 Aug 2024 02:00

Export record

Altmetrics

Contributors

Author: Jon E. Grant
Author: Sarah A. Redden
Author: Samuel R. Chamberlain ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×